Close Menu

NEW YORK – Adaptive Biotechnologies reported a 52 percent year-over-year increase in second quarter revenues after the close of the market on Tuesday.

For the quarter ended Sept. 30, 2019, Adaptive reported $26.1 million in revenues, up from $ 17.3 million during the year-ago period and beating the consensus Wall Street estimate of $22.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.